HCV Genotypes in Sera From HCV Patient Group 1 (RF activity >100 IU/mL) With and Without Cryoglobulins
| . | HCV Genotype . | ||||||
|---|---|---|---|---|---|---|---|
| n . | 1a . | 1b . | 2a . | 3a . | 4 . | Undetermined . | |
| Cryoglobulin type* | |||||||
| II | 4 | 0 | 2 | 1 | 0 | 0 | 1 |
| II-III | 10 | 0 | 8 | 0 | 2 | 0 | 0 |
| III | 22 | 1 | 5 | 2 | 9 | 2 | 3 |
| Total | 36 | 1 (2.8%) | 15 (42%) | 3 (8.4%) | 11 (30.1%) | 2 (5.6%) | 4 (11.1%) |
| No cryoglobulin | 24 | 1 (4.2%) | 6 (25%) | 3 (12.5%) | 10 (41.2%) | 0 (0%) | 4 (16.7%) |
| . | HCV Genotype . | ||||||
|---|---|---|---|---|---|---|---|
| n . | 1a . | 1b . | 2a . | 3a . | 4 . | Undetermined . | |
| Cryoglobulin type* | |||||||
| II | 4 | 0 | 2 | 1 | 0 | 0 | 1 |
| II-III | 10 | 0 | 8 | 0 | 2 | 0 | 0 |
| III | 22 | 1 | 5 | 2 | 9 | 2 | 3 |
| Total | 36 | 1 (2.8%) | 15 (42%) | 3 (8.4%) | 11 (30.1%) | 2 (5.6%) | 4 (11.1%) |
| No cryoglobulin | 24 | 1 (4.2%) | 6 (25%) | 3 (12.5%) | 10 (41.2%) | 0 (0%) | 4 (16.7%) |
*As analyzed by 2D-PAGE.